Venous thromboembolism
Conditions
Interventions
Rivaroxaban+ conventional nursing group:Rivaroxaban+ conventional nursing
Sponsors
Sun Yat-sen University Cancer Center
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged 18 years and more; 2. Cancer patients need to be detained PICC catheters; 3. Khorana Score =1 (Cancer patients with chemotherapy related VTE must at moderate risk or above); 4. ECOG Score =2 (Patients' physical state must in 50% in bed during the day (Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours or above); 5. Patients must be informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who are with high risk of bleeding; 2. Patients who are combined use of interacting drugs with rivaroxaban; 3. The patient or its authorized person is unwilling to sign a written informed consent or unwilling to comply with the clinical trial protocol; 4. Pregnant or breast-feeding women; 5. Life expectancy of less than or equal to (<=) 6 months; 6. Patients who have diagnosed of acute deep venous thrombosis past or present.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptomatic PICC Catheters related upper extremity venous thrombosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Upper / lower extremity deep venous thrombosis, pulmonary embolism and other parts of the venous thrombosis; | — |
Countries
China
Contacts
Public ContactXiuyu Cai
Sun Yat-sen University Cancer Center
Outcome results
None listed